GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (FRA:9LB) » Definitions » Short Interest

Legend Biotech (FRA:9LB) Short Interest


View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Legend Biotech's Short Interest

For the Biotechnology subindustry, Legend Biotech's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Legend Biotech's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Legend Biotech's Short Interest distribution charts can be found below:

* The bar in red indicates where Legend Biotech's Short Interest falls into.



Legend Biotech (FRA:9LB) Business Description

Traded in Other Exchanges
Address
2101 Cottontail Lane, Somerset, NJ, USA, 08873
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.

Legend Biotech (FRA:9LB) Headlines

No Headlines